← All trials
NCT05178901
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 10, 2022
- Primary completion
- Jan 31, 2023
- Completion date
- Jan 31, 2024
- First posted
- Jan 5, 2022
- Last posted
- Apr 20, 2022
- Enrollment
- 60
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Public Health Vaccines LLCLead sponsor
- Coalition for Epidemic Preparedness InnovationsCollaborator
- Johnson County Clin-TrialsOverall official - principal investigator
- Johnson County Clin-TrialsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.